Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β‐cyclodextrin in haematological patients with renal impairment-Reference-Cited by-同舟云学术

Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β‐cyclodextrin in haematological patients with renal impairment

Published:2016-06-21 Issue:10 Volume:59 Page:644-651
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Kim Si‐Hyun¹²³,Kwon Jae‐Cheol¹²,Park Chulmin²,Han Seunghoon⁴,Yim Dong‐Seok⁴,Choi Jae‐Ki¹²,Cho Sung‐Yeon¹²,Lee Hyo‐Jin¹²,Park Sun Hee¹²,Choi Su‐Mi¹²,Choi Jung‐Hyun¹²³,Yoo Jin‐Hong¹²,Lee Dong‐Gun¹²⁵,Lee Jong‐Wook¹⁵

Affiliation:

1. Division of Infectious Diseases Department of Internal Medicine College of Medicine The Catholic University of Korea Seoul Korea

2. Vaccine Bio Research Institute College of Medicine The Catholic University of Korea Seoul Korea

3. Division of Infectious Diseases Department of Internal Medicine College of Medicine The Catholic University of Korea Incheon St. Mary's Hospital Incheon Korea

4. Department of Pharmacology College of Medicine The Catholic University of Korea Seoul Korea

5. Catholic Blood and Marrow Transplantation Center College of Medicine The Catholic University of Korea Seoul St. Mary's Hospital Seoul Korea

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.12517

Reference41 articles.

1. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

2. Antifungal prophylaxis in haematology patients: the role of voriconazole

3. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation